Meta-Analysis: Multiple Drug Combinations of Bortezomib, Lenalidomide, and Thalidomide for First‐line Treatment in Adults with Transplant‐Ineligible Multiple Myeloma
15 Jan, 2020 | 00:54h | UTCMultiple drug combinations of bortezomib, lenalidomide, and thalidomide for first‐line treatment in adults with transplant‐ineligible multiple myeloma: a network meta‐analysis – Cochrane Library (free)
Commentary: Featured Review: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma – Cochrane Library (free)